Understanding the potential for dyslipidemia or other cardiovascular risk factors while determining an appropriate HAART regimen

This tool enables you to review data from controlled studies on the lipid effects of recommended antiretroviral regimens for initial therapy as well as ‘switch strategies’ in patients on suppressive antiretroviral therapy.

You can also view a convenient graphical summary of the key data from those studies and print the data and/or download corresponding slides.